Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In 4-6 months it will be at pennies. They have nothing, they have made no progress in 10+ years and Slilaty is 70 years old and a con man.
The point is it doesn't really matter because they have used that "18-24 months" timeline for over 10 years. They said 10 years ago that that was how far away from phase 1 clinical trials and 10 years later they are still saying the same thing.
I think they think it sounds good, but it also allows a long enough time period that most longs eventually drop out of this stock and they can find new suckers to buy in without a large portion of people that have heard their BS to warn new investors that it's a scam.
All the longs eventually abandon the stock and a new round of retail investors see a stock with a low entry pps and take a lotto ticket on this and the company can drop the same nonsense PRs to entice new investors to drive the price up enough to r/s, rinse and repeat.
He likely put it up to show that this company hasn't budged an inch on any of their supposed drugs in over 10 years, so when the company says 18-24 months before they anticipate clinical testing you know that they have been saying that for over 10 years and have never gotten any closer to starting those trials.
Agreed. They can only hope for a pump, and given this stocks history that doesn't seem very likely, or to be very big. They already got the pump and dumped it. At best I would say they might do something to try and pump in another year or so, but that will also likely come after another dump back to sub pennies.
They also said the same thing in 2011.
Probably because as merpennystocks pointed out they have been stuck at the same point in development on drugs since 2011. 11 years and no progress whatsoever, other than taking shareholder investments and crapping on them.
Something they have never done, over the course of 10-11 years of announcing new mice trials every few years. They just wait a while then announce some other mice trials. Been doing it since 2011/12 and never have announced any kind of results.
They've been starting mice trials as far back as 2011 for their cancer treatment (adva-27a) and never released any results on them.
Yeah, and they supposedly started mice studies 2 years ago, yet haven't begun clinical trials yet, which is a huge red flag, especially given this company's history of announcing preclinical studies for over 10 years and never reaching clinical studies.
I just wish JoeLahr were here to tell us how great this news is. I wonder where the last remaining cheerleader on this board has gone?
Nah he took advantage of the COVID BS cure news during the height of the pandemic.
This is just further proof of their ineptitude. They are referencing a marketing deal from 2016 where Sunshine was going to sell anastrozole and nothing ever came from it. Six years later they made no real money off of it and no longer are running the generic cancer drugs. This is literally further proof of their ineptitude at monetizing anything within the medical industry.
Exactly. I use that time frame as the absolute best case scenario to highlight a few things:
1) Slilaty is 70 years old and in 11 years hasn't made any significant progress in getting this from pre-clinical to phase 1 - the wording on what they have found about adva27a is almost identical now to what they knew 11 years ago - so a best case scenario of 3 years is beyond likely to get from pre clinical through phase 3 and put out a product.
2) Slilaty being 70 years old is far for likely to be slowing down, so expecting them to speed through clinical trials is highly unlikely.
3) This company has time and again bungled properly filing paperwork, from the OTCQB uptiering attempts to how they handled the NASDAQ up listing, which destroyed shareholder value while acquiring significantly less funding than they initially claimed they would get. If they can't properly file paperwork, what makes anyone think they will absolutely flawlessly speed through clinical trials (which they haven't even begun) for a disease that is one of the most widely studied and affecting of humanity, yet still one of the most brutally deadly and highly uncurable in human history?
4) on top of all that they haven't updated on the mice trials for adva27a started long past a year ago and in fact pivoted to a different preclinical trial for cancer involving the new hot buzz word of 'mRNA.'
The company shows it can't even complete preclinical mice trials with any results that they are willing to share, let alone any phase of clinical mice trials. The doctor is a senior citizen and even on the best and most improbably fast timeline, an actual product cure is at least 3 years away with everything going improbably perfectly, when this company has shown they don't even know how to file paperwork, or at least hire competent people to properly file paperwork, in multiple instances.
Long story short, there is no way this company will ever produce anything of value with Slilaty, and they have stated time and again they will lose what little value they have if he were ever to move on from the company.
11 years of saying they plan to start phase 1 trials is starting to seem like failing... Clinical trials take years to complete to reach an actual product being produced and sold. They haven't even begun clinical trials in 11 years of saying soon.
Also nobody cares about your retirement plans, they care about Slilaty's, and you are not him. And he is 70, at some point age forces you to retire.
https://www.fda.gov/patients/drug-development-process/step-3-clinical-research
Phase 1- several months to complete
Phase 2 - several months to 2 years
Phase 3 - 1 to 4 years
That's a bare minimum of 2 years just to get through phase 3, if everything works perfectly. Given this company's history of 11 years and still no clinical trials beginning, I'd say perfect is the last thing that their process has been.
There is plenty of reason to believe that because this company has given no indication of ever filing paperwork correctly or in a timely manner. They've also never gotten to phase 1 human trials for cancer drug even though they have been saying since 2011 they plan on starting them within 18-24 months. Never assume things are being done properly. You can hope that they are rectifying it, but you should never assume they are, especially given the company's history for incompetence.
They've stated the same time frame in the past on the 10Q annuals that they expect to start phase 1 trials on adva27a as far back as 2011 or 2012
Probably how they planned it.
Right, lol
No we lost 90% of the chatter because this company hasn't produced anything material after touting over a year ago both promising COVID and cancer mice trials.
Ah I see, the handle On millionaire sounds vaguely familiar, but I don't remember him posting here a whole lot.
Uh... What? Explanation and proof please.
Same. It doesn't help that the economy is in the process of circling the toilet bowl. It is odd that they pushed to get on Nasdaq without having anything material, but I'd sooner believe that than they have something until they actually release substantial news. I won't be holding my breath, and as evidenced by the total abandonment of this board by all the blind pumpers, I assume most everyone that was long invested in this feels the same way.
Yeah, not sure what that is about, it could be they are going to try and pump, but I can't imagine they can withhold news on mice trial results as that would be material information and require being published within a short timespan. There is a glimmer of hope in him buying 25k shares, but this company has pretty much fumbled everything for the past year+. Also add to that that they've done 3 r/s in 4 years and have been saying they expect to go to phase 1 trials on cancer treatment since 2011 and there is just too much bullshit to ignore or expect this company to pull their head out of their ass until they produce something concrete and actually progressive of any treatment drug to human trials.
I assume it's more reluctance than inability. The fact that their website posts a fluff PR or two each month about the importance of supplements. If they had anything substantial they would not give a shit about the supplement hustle. Also the fact that they pivoted the most recent actual biomedical PR to mRNA treatment with cancer as opposed to discussing whatever happened with the mice trials they already had begun with their cancer drug and COVID compounds.
Screams of desperation to me.
I mean that's been the pattern for this since 2017.
At least to the point of starting phase 1 human trials, where they actually test if the science works at the most basic human level, which apparently it doesn't yet to even consider trying to test.
I hear ya, it's just given their history of promising the intent to go to human trials and then nothing ever happening, at some point got to get out. The only sliver of hope is that they are on the Nasdaq now, so they might actually be serious about getting to human trials, but it's hard to ignore the history in addition to the way they destroyed loyal shareholders and the damn share price to get on the Nasdaq.
Luckily I got in around a penny and a half when they were on the OTC (which is roughly about $3 after the reverse split) but I also sold just under a quarter of my shares around $0.10 before all the reverse split f$ckery for a nice $3k profit.
It's just sad knowing at one point I could have sold all my shares for over $100k profit, but didn't, thinking they would eventually announce updates on the mice trials for COVID or cancer and that it would go higher. Live and learn.
Hopefuy they have legit treatments and they actually push forward with them. But the more time that passes, the more it looks like they are full of sh!t. Well over a year since they started COVID and cancer mice trials and still nothing on either front.
It's becoming increasingly likely, unless they actually announce phase 1 human trials commence. But I'm not holding my breath on that one.
That's how they've done it with their cancer drug, saying in 10Ks that they expect to go to phase 1 trials within 9-18 months as far back as 2012 and never doing sh!t about it. They've gotten funding in the past and do jack with it. Its pump and dump
What I am trying to figure out is that the number of shares is definitely changing on that list (increasing), but the date is affixed at 3/31/22 (except for one company that is set to 12/31/21).
Are these shares being exercised from warrants issued from the offering? Or are they just starting from the initial date they bought shares?
It also wasn't until I believe today (might have been last week) that the total shares was actually updated from the 7+ million to the 16+ million it is currently at. Just trying to figure out what is going on with this process, seems like they haven't quite finished updating all the aftermath of the offering.
Oh I know, that's why none of this institutional investor nonsense means much to me, especially in the small amounts they are accumulating. This stock will only ever make investors good money when they actually progress their drugs. That's the only thing that will move this forward and restore any shareholder confidence. Otherwise it's all just a bunch of flippers and bag holders, institutional or otherwise.
Nice try. But when I posted it was 8 institutional holders at about 795k shares. It's nice that the number of shares have increased and the number of institutional holders is increasing, hopefully that trend continues. But they really need to release forward progress with their drug trials.
Institutional investors can hype and flip like anyone else on the promise of a newly listed Nasdaq stock. But this company won't gain any trust back from me until they are officially in phase 1. Hope it happens, I still hold a grip of shares, but I also got profit out before the 200:1 r/s because too many things were looking shady. Sure enough they were because this thing has to hit $60 to equate to the previous high of $.30 from the OTC last year. $2 to $60 is a big jump to make even if they announced phase 1 trials.
Because most all the important facts have been stated. Where are mice results? Why have they not gotten to phase 1 cancer testing in over ten years of in vitro tests? Why have they done 3 reverse splits in 4 years while also being incredibly shady about how they disclosed and changed the terms this last time? Where are results now that all the 'quiet periods' have all come and gone?
None of these questions are answered and all the pumpers do is grasp at straws and try to hail it as something so falsely over hyped that it has to be called out.
The actual number of shares was finally updated after all the f*ckery of the reverse split and offering with packaged warrants. It sits at 16 million shares. The institutional investors in total hold less than 800k shares. Not exactly encouraging.
He hasn't gotten them there in 10+ years of trying and is entering an age where retirement is a strong possibility. Also phase 1/2/3 trials aren't a walk in the park, they can take years, cumulatively, to complete. Also the share price has absolutely plummeted. All signs point to this being a total bust.
When the CEO of a company is at that age, and when their 10Ks consistently remark on how integral he is to the company being successful, it's something to seriously consider when investing.
They are still at least a couple/few years away from bringing anything to market, if they even have anything viable. They haven't gotten their cancer drug past mice trials in 10 years of planning to go to phase 1. They are 9-18 months, minimum, away from entering phase 1 trials (they have been using that "9-18 months" line as far back as the 2012 10K), and even if they pass those trials it would still be 6-12 months minimum to get to phase 3 and another 6-12 month to pass that. And, those are big ifs. So yeah, the indispensable CEO being 70 while they still haven't gotten to phase 1 (after 10+ years of trying) is very important consideration. If he were 45-50, hell even 60, it would be much less concerning. But he is 70 and that is an age range where retirement is a very possible eventuality.
Pretty sure 10+ years of not getting past mice trials and the CEO/lead doctor being 70 are pretty good indicators they aren't going to get anywhere.
I don't know why you say it will get there. They've already said phase 1 testing is 9-18 months away, which that alone wouldn't raise the share price nearly that high. To get the share price remotely there would take having an actual drug be brought to market. If phase 1 is 9-18 months away, that means years before getting past phase 3, and most potential drug treatments never get past phase 2 let alone phase 3.
Take into account that they have been saying they expect to get to phase 1 on cancer drug in 9-18 months as far back as 2011, and this just sounds like more posturing. Hell they haven't even released the mice results from testing started over 1 year ago.
They have nothing, that's why the stock price plummeted after the reverse split.
You hope this drops to the .17 - .24 range? Or go up to the equivalent of that pre-reverse split?
Because to get there it has to go from $2 to $34-48. That is not going to happen any time soon, if ever.
Dated from 2 days ago